WOIPPY, MOSELLE, FRANCE, May 21, 2026 — ABL Diagnostics (FR001400AHX6 – “ABLD”) (the “Company”), a specialist in molecular diagnostics, bioinformatics and infectious disease solutions, today announces the strategic acceleration of its exclusive partnership with VELA Diagnostics for the EMEA…